Ch. 103

1996 LAWS OF MARYLAND

(i) Exclusion of coverage for classes of drugs as specified by contract;
(ii) Changes in prior or preauthorization procedures; and
(iii) Selection of new prescription claims processors.

(3)     If the Maryland Pharmacy Assistance Program fails to provide advance
notice as required under paragraph (1) of this subsection, it shall honor and pay in full
any claim under the Program rules or requirements that existed before the change for 30
days after the postmarked date of the notice.

(4)     NOTWITHSTANDING ANY OTHER PROVISION OF LAW, THE NOTICE
REQUIREMENTS OF THIS SUBSECTION DO NOT APPLY TO THE ADDITION OF NEW
GENERIC DRUGS AUTHORIZED UNDER § 12-508 OF THE HEALTH OCCUPATIONS
ARTICLE

SECTION 4. AND BE IT FURTHER ENACTED, That Section 3 of this Act is
contingent on the taking effect of the termination provision specified in Section 3 of
Chapter 401 of the Acts of the General Assembly of 1991. If that termination provision
takes effect, Section 2 of this Act shall be void. This Act may not be interpreted to have
any effect on that termination provision.

SECTION 5. AND BE IT FURTHER ENACTED, That, subject to the
provisions of Section 4 of this Act, this Act shall take effect July 1, 1996.

Approved April 30, 1996.

CHAPTER 103
(Senate Bill 105)

AN ACT concerning

Reporting of Communicable Diseases

FOR the purpose of adding to a list of diseases that are reportable by a director of a
medical laboratory to a certain health officer within a specified period of time; and
generally relating to the reporting of certain diseases by medical laboratories.

BY repealing and reenacting, with amendments,
Article - Health - General
Section 18-205(a)(1)
Annotated Code of Maryland
(1994 Replacement Volume and 1995 Supplement)

SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF
MARYLAND, That the Laws of Maryland read as follows:

- 1368 -